مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers.
Normal view MARC view ISBD view

PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers. [electronic resource]

By:
  • Wang, Q
Contributor(s):
  • Liu, P
  • Spangle, J M
  • Von, T
  • Roberts, T M
  • Lin, N U
  • Krop, I E
  • Winer, E P
  • Zhao, J J
Producer: 20170911Description: 3607-12 p. digitalISSN:
  • 1476-5594
Subject(s):
  • Animals
  • Breast Neoplasms -- drug therapy
  • Cell Line, Tumor
  • Cell Survival -- drug effects
  • Class I Phosphatidylinositol 3-Kinases
  • Drug Resistance, Neoplasm -- drug effects
  • Female
  • Humans
  • Lapatinib
  • Mammary Neoplasms, Experimental -- drug therapy
  • Mice, Knockout
  • Molecular Targeted Therapy -- methods
  • PTEN Phosphohydrolase -- deficiency
  • Phosphatidylinositol 3-Kinases -- genetics
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors -- pharmacology
  • Proto-Oncogene Proteins c-akt -- metabolism
  • Quinazolines -- pharmacology
  • Receptor, ErbB-2 -- antagonists & inhibitors
  • Signal Transduction -- drug effects
  • Thiazoles -- pharmacology
  • Tumor Burden -- drug effects
  • Xenograft Model Antitumor Assays
Online resources:
  • Available from publisher's website
In: Oncogene vol. 35
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 81
  • 82
  • 81 Research Priorities in the Field of Posttraumatic Pain and Disability: Results of a Transdisciplinary Consensus-Generating Workshop.
    by Walton, David M
  • 82 The AURORA Study: a longitudinal, multimodal library of brain biology and function after traumatic stress exposure.
    by McLean, Samuel A
Close

PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers.

APA

Wang Q., Liu P., Spangle J. M., Von T., Roberts T. M., Lin N. U., Krop I. E., Winer E. P. & Zhao J. J. (20170911). PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers. : Oncogene.

Chicago

Wang Q, Liu P, Spangle J M, Von T, Roberts T M, Lin N U, Krop I E, Winer E P and Zhao J J. 20170911. PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers. : Oncogene.

Harvard

Wang Q., Liu P., Spangle J. M., Von T., Roberts T. M., Lin N. U., Krop I. E., Winer E. P. and Zhao J. J. (20170911). PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers. : Oncogene.

MLA

Wang Q, Liu P, Spangle J M, Von T, Roberts T M, Lin N U, Krop I E, Winer E P and Zhao J J. PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers. : Oncogene. 20170911.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site